This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCoy, C.
Right arrow Articles by Cornwell, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCoy, C.
Right arrow Articles by Cornwell, M. M.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 11 1995, 6100-6108, Vol 15, No. 11
Copyright © 1995, American Society for Microbiology

12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1

C McCoy, DE Smith and MM Cornwell
Clinical Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, USA.

P-glycoprotein, the product of the MDR1 gene (multidrug resistance gene 1), is an energy-dependent efflux pump associated with treatment failure in some hematopoietic malignancies. Its expression is regulated during normal hematopoietic differentiation, although its function in normal hematopoietic cells is unknown. To identify cellular factors that regulate the expression of MDR1 in hematopoietic cells, we characterized the cis- and trans-acting factors mediating 12-O- tetradecanoylphorbol-13-acetate (TPA) activation of the MDR1 promoter in K562 cells. Transient-transfection assays demonstrated that an MDR1 promoter construct containing nucleotides -69 to +20 conferred a TPA response equal to that of a construct containing nucleotides -434 to +105. TPA induced EGR1 binding to the -69/+20 promoter sequences over a time course which correlated with increased MDR1 promoter activity and increased steady-state MDR1 RNA levels. The -69/+20 promoter region contains an overlapping SP1/EGR site. The TPA-responsive element was localized to the overlapping SP1/EGR site by using a synthetic reporter construct. A mutation in this site that inhibited EGR protein binding blocked the -69/+20 MDR1 promoter response to TPA. The expression of a dominant negative EGR protein also blocked the TPA response of the - 69/+20 promoter construct. Finally, the expression of EGR1 was sufficient to activate a construct containing tandem MDR1 promoter SP1/EGR sites. These data suggest a role for EGR1 in modulating MDR1 promoter activity in hematopoietic cells.


This article has been cited by other articles:

  • Mickley Huff, L., Wang, Z., Iglesias, A., Fojo, T., Lee, J.-S. (2005). Aberrant Transcription from an Unrelated Promoter Can Result in MDR-1 Expression following Drug Selection In vitro and in Relapsed Lymphoma Samples. Cancer Res. 65: 11694-11703 [Abstract] [Full Text]  
  • Kuwano, M., Oda, Y., Izumi, H., Yang, S.-J., Uchiumi, T., Iwamoto, Y., Toi, M., Fujii, T., Yamana, H., Kinoshita, H., Kamura, T., Tsuneyoshi, M., Yasumoto, K., Kohno, K. (2004). The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Molecular Cancer Therapeutics 3: 1485-1492 [Abstract] [Full Text]  
  • Chen, G. K., Sale, S., Tan, T., Ermoian, R. P., Sikic, B. I. (2004). CCAAT/Enhancer-Binding Protein {beta} (Nuclear Factor for Interleukin 6) Transactivates the Human MDR1 Gene by Interaction with an Inverted CCAAT Box in Human Cancer Cells. Mol. Pharmacol. 65: 906-916 [Abstract] [Full Text]  
  • Terskikh, A. V., Miyamoto, T., Chang, C., Diatchenko, L., Weissman, I. L. (2003). Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 102: 94-101 [Abstract] [Full Text]  
  • Davis, W. Jr, Chen, Z. J., Ile, K. E., Tew, K. D. (2003). Reciprocal regulation of expression of the human adenosine 5'-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors. Nucleic Acids Res 31: 1097-1107 [Abstract] [Full Text]  
  • Comerford, K. M., Wallace, T. J., Karhausen, J., Louis, N. A., Montalto, M. C., Colgan, S. P. (2002). Hypoxia-inducible Factor-1-dependent Regulation of the Multidrug Resistance (MDR1) Gene. Cancer Res. 62: 3387-3394 [Abstract] [Full Text]  
  • Deucher, A., Efimova, T., Eckert, R. L. (2002). Calcium-dependent Involucrin Expression Is Inversely Regulated by Protein Kinase C (PKC)alpha and PKCdelta. J. Biol. Chem. 277: 17032-17040 [Abstract] [Full Text]  
  • Sampath, J., Sun, D., Kidd, V. J., Grenet, J., Gandhi, A., Shapiro, L. H., Wang, Q., Zambetti, G. P., Schuetz, J. D. (2001). Mutant p53 Cooperates with ETS and Selectively Up-regulates Human MDR1 Not MRP1. J. Biol. Chem. 276: 39359-39367 [Abstract] [Full Text]  
  • Kumar, A., Soprano, D. R., Parekh, H. K. (2001). Cross-Resistance to the Synthetic Retinoid CD437 in a Paclitaxel-resistant Human Ovarian Carcinoma Cell Line Is Independent of the Overexpression of Retinoic Acid Receptor-{gamma}. Cancer Res. 61: 7552-7555 [Abstract] [Full Text]  
  • Yang, J.-M., Vassil, A. D., Hait, W. N. (2001). Activation of Phospholipase C Induces the Expression of the Multidrug Resistance (MDR1) Gene through the Raf-MAPK Pathway. Mol. Pharmacol. 60: 674-680 [Abstract] [Full Text]  
  • Scotto, K. W., Johnson, R. A. (2001). Transcription of MDR1: A Therapeutic Target. Mol. Interv. 1: 117-125 [Abstract] [Full Text]  
  • Bartsevich, V. V., Juliano, R. L. (2000). Regulation of the MDR1 Gene by Transcriptional Repressors Selected Using Peptide Combinatorial Libraries. Mol. Pharmacol. 58: 1-10 [Abstract] [Full Text]  
  • Chapman, N. R., Perkins, N. D. (2000). Inhibition of the RelA(p65) NF-kappa B Subunit by Egr-1. J. Biol. Chem. 275: 4719-4725 [Abstract] [Full Text]  
  • Hu, Z., Jin, S., Scotto, K. W. (2000). Transcriptional Activation of the MDR1 Gene by UV Irradiation. ROLE OF NF-Y AND Sp1. J. Biol. Chem. 275: 2979-2985 [Abstract] [Full Text]  
  • Fry, C. J., Farnham, P. J. (1999). Context-dependent Transcriptional Regulation. J. Biol. Chem. 274: 29583-29586 [Full Text]  
  • McCoy, C., McGee, S. B., Cornwell, M. M. (1999). The Wilms' Tumor Suppressor, WT1, Inhibits 12-O-Tetradecanoylphorbol-13-acetate Activation of the Multidrug Resistance-1 Promoter. Cell Growth Differ. 10: 377-386 [Abstract] [Full Text]  
  • Thottassery, J. V., Sun, D., Zambetti, G. P., Troutman, A., Sukhatme, V. P., Schuetz, E. G., Schuetz, J. D. (1999). Sp1 and Egr-1 Have Opposing Effects on the Regulation of the Rat Pgp2/mdr1b Gene. J. Biol. Chem. 274: 3199-3206 [Abstract] [Full Text]  
  • Zhou, G., Kuo, M. T. (1997). NF-kappa B-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells. J. Biol. Chem. 272: 15174-15183 [Abstract] [Full Text]  
  • Sundseth, R., Macdonald, G., Ting, J., King, A. C. (1997). DNA Elements Recognizing NF-Y and Sp1 Regulate the Human Multidrug-Resistance Gene Promoter. Mol. Pharmacol. 51: 963-971 [Abstract] [Full Text]  
  • Das, A., Chendil, D., Dey, S., Mohiuddin, M., Mohiuddin, M., Milbrandt, J., Rangnekar, V. M., Ahmed, M. M. (2001). Ionizing Radiation Down-regulates p53 Protein in Primary Egr-1-/- Mouse Embryonic Fibroblast Cells Causing Enhanced Resistance to Apoptosis. J. Biol. Chem. 276: 3279-3286 [Abstract] [Full Text]  
  • Vilaboa, N. E., Galan, A., Troyano, A., de Blas, E., Aller, P. (2000). Regulation of Multidrug Resistance 1 (MDR1)/P-glycoprotein Gene Expression and Activity by Heat-Shock Transcription Factor 1 (HSF1). J. Biol. Chem. 275: 24970-24976 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»